A Randomized Trial of Rosuvastatin in the Prevention of Venous Thromboembolism | Zendy

Robert J. Glynn | Zendy; Eleanor Danielson | Zendy; Francisco Antônio Helfenstein Fonseca | Zendy; Jacques Genest | Zendy; Antonio M. Gotto | Zendy; John J.P. Kastelein | Zendy; Wolfgang Köenig | Zendy; Peter Libby | Zendy; Alberto J. Lorenzatti | Zendy; Jean MacFadyen | Zendy; Børge G. Nordestgaard | Zendy; James Shepherd | Zendy; James T. Willerson | Zendy; Paul M. Ridker | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

A Randomized Trial of Rosuvastatin in the Prevention of Venous Thromboembolism

Author(s) -

Robert J. Glynn,

Eleanor Danielson,

Francisco Antônio Helfenstein Fonseca,

Jacques Genest,

Antonio M. Gotto,

John J.P. Kastelein,

Wolfgang Köenig,

Peter Libby,

Alberto J. Lorenzatti,

Jean MacFadyen,

Børge G. Nordestgaard,

James Shepherd,

James T. Willerson,

Paul M. Ridker

Publication year - 2009

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa0900241

Subject(s) - medicine , rosuvastatin , randomized controlled trial , observational study , venous thrombosis , intensive care medicine , venous thromboembolism , statin , cardiology , thrombosis

Controversy persists regarding the extent of shared pathways between arterial and venous thrombosis and whether treatments of known efficacy for one disease process have consistent benefits for the other. Observational studies have yielded variable estimates of the effect of statin therapy on the risk of venous thromboembolism, and evidence from randomized trials is lacking.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research